Responses
Poster Presentations
Validation of outcome measures and biomarkers
THU0691 Is serum amyloid a protein an useful biomarker to monitor treatment with anti-tumour necrosis factor-alpha agents in spondyloarthritis patients?
Compose a Response to This Article
Other responses
No responses have been published for this article.